• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about Biogen Inc

    Recent news which mentions Biogen Inc

    < Previous 1 2 3 4 Next >
    Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
    Tags Economy Finance Raytheon Technologies Corp
    From CNBC.com News
    Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
    Tags Pharmaceuticals Health & Science Wells Fargo & Co
    From CNBC.com News
    5 things to know before the stock market opens Tuesday
    Tags Citigroup Inc Business Investing
    From CNBC.com News
    Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
    Tags Eli Lilly and Co Pharmaceuticals Biotech and Pharmaceuticals
    From CNBC.com News
    Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
    Tags Science Biotechnology Alzheimer's disease
    From CNBC.com News
    Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
    Tags Alzheimer's disease Companies Biotechnology
    From CNBC.com News
    Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
    Tags Biogen Inc TG Therapeutics Inc Market Insider
    From CNBC.com News
    Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
    Tags Costco Wholesale Corp Meta Platforms Inc Economy
    From CNBC.com News
    Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
    Tags Science Biogen Inc Biotech and Pharmaceuticals
    From CNBC.com News
    FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
    Tags Health care industry US: News World News
    From CNBC.com News
    Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
    Tags Urban Outfitters Inc Markets JD/Com Inc
    From CNBC.com News
    FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
    Tags U/S/ Economy Business US Top News and Analysis
    From CNBC.com News
    Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
    Tags Business U/S/ Economy Alzheimer's disease
    From CNBC.com News
    Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
    Tags TJX Companies Inc Investment strategy U/S/ Markets
    From CNBC.com News
    Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
    Tags Eisai Co Ltd Health & Science Biotechnology
    From CNBC.com News
    Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
    Tags Western Alliance Bancorp Business Advanced Micro Devices Inc
    From CNBC.com News
    Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
    Tags Biotech and Pharmaceuticals World News Policy
    From CNBC.com News
    Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
    Tags Breaking News: Business Biogen Inc Coronavirus
    From CNBC.com News
    Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
    Tags Eisai Co Ltd Health & Science Social issues
    From CNBC.com News
    Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
    Tags Pharmaceuticals Eli Lilly and Co Biogen Inc
    From CNBC.com News
    FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
    Tags Health & Science Breaking news Ionis Pharmaceuticals Inc
    From CNBC.com News
    Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
    Tags Breaking news Eisai Co Ltd Health & Science
    From CNBC.com News
    Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
    Tags Companies Science Biotechnology
    From CNBC.com News
    FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
    Tags Breaking News: Business Biotechnology Biogen Inc
    From CNBC.com News
    FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
    Tags Health care industry US: News Biotech and Pharmaceuticals
    From CNBC.com News
    Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
    Tags World News Biotech and Pharmaceuticals Policy
    From CNBC.com News
    FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
    Tags Business U/S/ Economy US Top News and Analysis
    From CNBC.com News
    Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
    Tags Biotechnology US Top News and Analysis U/S/ Economy
    From CNBC.com News
    Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more
    Tags Bio Rad Laboratories Inc Roku Inc Economy
    From CNBC.com News
    Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
    Tags Epidemics Pandemics US Economy
    From CNBC.com News
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.